LINCOTEK
Global contract manufacturer Lincotek announced today that it has signed an agreement to acquire a majority stake in Italy-based Pegasus’ medical division. The Alaria family will remain fully involved in the business, with Alberto Alaria taking the position of Managing Director of the new entity.
The move will further strengthen the Medical Division of Lincotek Group , which is continuing its global investment program to respond to ever-more demanding customer requirements in terms of integrated solutions. Through new technologies and automation, the company is addressing the growing interest of the orthopedic device market in an automated forging service, increasing efficiency along the supply chain, setting new standards around quality and reliability and further reducing lead time.
The investment represents an important addition to an already comprehensive set of capabilities that Lincotek Medical has in-house and enhances the company’s competitive edge, adding unique, state-of- the-art capabilities in the forging field.
Established in 2007 in Torino, northern Italy, Pegasus decided in 2019 to expand its innovative forging processes into the medical market. The brand-new facility - with a surface area of around 3,000 sqm - is completely dedicated to orthopedic applications, being ISO 13485 certified and having an ISO 17025 certified internal laboratory. Lincotek’s forging offers a unique level of automation through the manufacturing process ensuring state-of-the-art product quality, total process control and repeatability.
The fully robotized forging line - which allows the manufacture of high-quality forged implantable parts to customer specifications – is the flagship of a complete production service of forged components. Its capabilities are combined with a state-of-the-art, AMS-2750-compliant heat treatment furnace ; automated pickling line and liquid penetrant inspection unit ; laboratory equipment; internal mold manufacturing; robotized deburring and polishing unit; and computerized dimensional control.
Lincotek Medical will therefore offer a new, impressive, high-volume capacity, through single service or fully-integrated solutions to support OEMs with a strategic long-term partnership.
Winfried Schaller, CEO of Lincotek Group commented: “With the acquisition of the majority stake in Pegasus medical division, Lincotek Medical is in a stronger position than ever before to support orthopedic OEMs. By combining this impressive forging service with our existing offering, we are able to help customers stay competitive and get to market even faster. It really is a new world of advanced automation and productivity.”
Speaking for Pegasus, Alberto Alaria, the company’s Managing Director, said: “Pegasus is proud to enter into partnership with Lincotek Group which represents a great opportunity to grow our presence in the forged medical implants market with the offering of high-quality products. The new synergies and product integration that will be generated moves us a step ahead and creates the possibility of further strengthening the cooperation with our valued customers.”
Bringing this full suite of processes in-house, orthopedic OEMs can now rely on a well-established partner, which has broad capabilities and brings together the core competencies of R&D, product design, regulatory affairs, and manufacturing all under one roof, keeping focus on their core competencies.
About Lincotek
Lincotek, headquartered in Rubbiano, Parma - Italy, is a global contract manufacturer for services in niche markets including Industrial Gas Turbines, Aviation and Medical Device applications, as well as a leading manufacturer of industrial coating equipment and one of the most respected producers in the Additive Manufacturing field. The Group is family-owned and has more than 1,300 employees located in 17 production facilities across Europe, North America and Asia.
About Pegasus
Established in Favria, Torino (Italy) in 2007 on a 100,000 sqm site, of which 20,000 is covered, PEGASUS has forging, heat treating, machining and NDT inspection capabilities for the production of forged and rolled components for Industrial and Medical purposes.
For more information, please visit lincotek.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220321005021/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Tigo Energy Adds Dynamic Rate Management for EI Residential Solar-Plus-Storage Solution in EU9.12.2025 05:00:00 CET | Press release
Tigo EI Residential solar-plus-storage solution moves with real-world demand through a new smart feature that maximizes savings and grid independence. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced the addition of Dynamic Rate Management to the Tigo EI Residential solar-plus-storage solution. This new capability enables Tigo all-in-one ecosystem to intelligently respond dynamically to changes in electricity rates. This addition of Dynamic Rate Management comes at a time when European energy companies are rapidly expanding the use of dynamic rates across several EU nations. The Dynamic Rate Manager will be available for new Tigo EI customers as well as existing EI Residential system owners as a part of a software update with no additional hardware, accessories, or configuration required. The Dynamic Rate Management feature allows the EI Residential solution to automatically acquire and interp
SII Begins Mass Production of the World’s Smallest (1.0 × 0.8 × 0.32mm) Tuning-Fork Crystal Resonator “SC-10S”9.12.2025 03:00:00 CET | Press release
Achieving Both a 33% Reduction in Mounting Area and Low ESR Seiko Instruments Inc. (President: Yoichi Endo; Headquarters: Chiba City, Chiba Prefecture; hereinafter “SII”) will begin mass production of the “SC-10S” (32.768kHz), the world’s smallest* tuning-fork crystal resonator measuring 1.0 × 0.8mm, starting in April 2026. *Based on SII research as of November 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202800779/en/ Product Image-1 [Background of Development] SII has already been mass-producing the “SC-12S” (32.768kHz), one of the world’s smallest tuning-fork crystal resonators at 1.2 × 1.0mm. As wearable devices such as smart rings and smartwatches, as well as IoT devices, continue to become smaller, the electronic components built into these devices are increasingly required to support high-density mounting, low power consumption, and high performance. To meet these needs, SII leveraged its proprietary photol
Verimatrix: Signing of an Agreement for the Sale of XTD Assets (Code and Application Protection) to Guardsquare8.12.2025 17:45:00 CET | Press release
Sale of XTD assets (mobile application protection) including a portfolio of patents and a team of experts for an initial offer of $8.5m, the final price will be adjusted at the closing.Verimatrix refocuses on Anti-Piracy (video protection), the group's core business representing approximately 90% of its total revenue Regulatory News: VERIMATRIX (Euronext Paris: VMX, FR0010291245), a leading provider of user security solutions for a safer connected world, announces the signing of an agreement with Belgium-based Guardsquare, the leading provider of mobile application security, for the sale of its Extended Threat Defense (XTD) assets. Guardsquare, the creators of the open-source optimization tool, ProGuard, offers the most complete mobile application security platform on the market spanning automated testing and multi-layered protection, real time threat monitoring, and app attestation. Guardsquare’s 975+ customers are located in more than 95 countries and represent all major industries.
WNBA Champion Sabrina Ionescu Becomes Global Brand Ambassador for Ant International8.12.2025 17:00:00 CET | Press release
Four-time WNBA All-Star Sabrina Ionescu today becomes a new Global Brand Ambassador for Ant International, a leading global provider of digital payments, digitisation, and financial technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251208536426/en/ The partnership is built on a shared commitment to creating a more inclusive and sustainable world through empowering underserved communities and youth groups with sports and technology innovation. It marks an important step in Ant International’s journey to foster growth and expand access to financial tools through innovative technology. Ionescu serves as the first Ant International global brand ambassador from North America. “Sabrina embodies the spirit of perseverance and the passion for excellence that is driving young talents and small businesses around the world to uplift their communities,” said Douglas Feagin, President of Ant International. “As a legend in a spor
SABCS 2025: REVEAL GENOMICS Presents Major Advance in Predicting Brain Metastasis in HER2+ Breast Cancer8.12.2025 16:20:00 CET | Press release
The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest risk of CNS involvement. During SABCS 2025, the company presents a total of 7 studies with 1,300 tumor samples analyzed, covering HER2-positive, ER-negative, and triple-negative breast cancer (TNBC), representing one of the largest and most comprehensive genomic data contributions to the symposium. New clinical evidence includes superior pCR prediction compared with TILs, demonstration of real-time genomic testing feasibility in an international trial, and validation of RNA-based ERBB2 assessment to accelerate clinical decision-making. REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker innovation, announced today the presentation of seven studies at the upcoming San Antonio Breast Cancer Symposium (SABCS) 2025, held Decem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom